BGI Genomics Co., Ltd. (SHE:300676)
53.23
+2.17 (4.25%)
Sep 8, 2025, 11:42 AM CST
BGI Genomics Revenue
BGI Genomics had revenue of 959.56M CNY in the quarter ending June 30, 2025, a decrease of -8.63%. This brings the company's revenue in the last twelve months to 3.63B, down -12.59% year-over-year. In the year 2024, BGI Genomics had annual revenue of 3.87B, down -11.10%.
Revenue (ttm)
3.63B
Revenue Growth
-12.59%
P/S Ratio
5.40
Revenue / Employee
979.73K
Employees
3,702
Market Cap
19.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.87B | -482.72M | -11.10% |
Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
Dec 31, 2020 | 8.40B | 5.60B | 199.86% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |